Template:Nifedipine: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 4: Line 4:
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | NIFEDIPINE<sup>®</sup> FDA Package Insert
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | NIFEDIPINE<sup>®</sup> FDA Package Insert
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ indications and usage|Indications and Usage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Nifedipine indications and usage|Indications and Usage]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Nifedipine dosage and administration|Dosage and Administration]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Nifedipine dosage and administration|Dosage and Administration]]
Line 12: Line 12:
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Nifedipine contraindications|Contraindications]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Nifedipine contraindications|Contraindications]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Nifedipine warnings and precautions|Warnings and Precautions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Nifedipine warnings |Warnings]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Nifedipine precautions|Precautions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Nifedipine adverse reactions|Adverse Reactions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Nifedipine adverse reactions|Adverse Reactions]]
Line 25: Line 27:
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Nifedipine clinical pharmacology|Clinical Pharmacology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Nifedipine clinical pharmacology|Clinical Pharmacology]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Nifedipine nonclinical toxicology|Nonclinical Toxicology]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Nifedipine clinical studies|Clinical Studies]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Nifedipine how supplied storage and handling|How Supplied/Storage and Handling]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Nifedipine how supplied storage and handling|How Supplied/Storage and Handling]]

Latest revision as of 23:11, 26 February 2014